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Appropriate combinations of mechanical and biological stimuli are required to promote 
proper colonization of substrate materials in regenerative medicine. In this context, 3D 
scaffolds formed by compatible and biodegradable materials are under continuous 
development in an attempt to mimic the extracellular environment of mammalian cells. 
We have here explored how novel 3D porous scaffolds constructed by polylactic acid, 
polycaprolactone or chitosan can be decorated with bacterial inclusion bodies, 
submicron protein particles formed by releasable functional proteins. A dipping-based 
decoration method specifically favors the penetration of the functional particles up to 
300 µm from the materials’ surface. The functionalized surfaces supports the 
intracellular delivery of biologically active proteins to up to more than 80 % of the 
colonizing cells, a process that is slightly influenced by the chemical nature of the 
scaffold. The combination of 3D soft scaffolds and protein-based sustained release 
systems (bioscaffolds) offers promise in the fabrication of bio-inspired hybrid matrices 
for multifactorial control of cell proliferation in tissue engineering under complex 
architectonic setting-ups.  
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Regenerative medicine pursues the reconstruction of damaged tissues by the 
controlled growth of cells, either in vitro followed by implantation or directly in vivo. As a 
pivotal concept supporting this approach, cells must be cultured on biocompatible 
substrates that should ideally provide the right combination of mechanical and 
biological stimuli for colonization, proliferation and, eventually, for differentiation [1,2]. 
Reaching an appropriate spatial distribution of cells would be in general convenient, but 
it is specifically demanded in the case of tissues formed by heterogeneous mixtures of 
cell types. The use of metal nanoparticles and magnetic force is of special interest as it 
permits a fine control and volumetric distribution of diverse cell lineages in 
architectonically complex organic structures [3]. More generally, 3D scaffolds are under 
development to provide cell friendly substrates for cell attachment and proliferation, 
mimicking the intercellular matrix and the natural cell environment more efficiently than 
the conventional 2D surfaces used in plain cell culture. Apart from metals, ceramics, 
protein-based hydrogels and carbon nanotubes, a spectrum of biocompatible and 
biodegradable polymers is being explored for 3D culture useful ex vivo and for 
implantation, including hyaluronic acid (HA), polylactic acid (PLA), polyglycolic acid 
(PLGA), chitosan (CHT), polycaprolactone (PCL), polyanhidrides, polyorthoesters and 
dendrimers [2,4-6]. Controlling the material’s architecture during biofabrication permits 
to define porosity for mass transfer and proper colonization of the inner surfaces [7]. In 
addition, 3D scaffolds are expected to offer unordered mechanical stimuli for mechano-
transduction events [8], required for a fine control of cell response [9], more efficiently 
than 2D substrates. Ideally, mechanical stimulation should act synergistically with 
biological signals, among which soluble protein factors such as insulin-like growth 
factor I [10], nerve growth factor β [11,12], epidermal growth factor [13], 
osteoprotegerin [14], fibroblast growth factors [15], and vascular endothelial growth 
factor [15] are the most effective. While being naturally available in vivo, they must be 
externally supplied in ex vivo cell culture.  
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In the last years, bacterial inclusion bodies (IBs) have been revealed as adhesive but 
mechanically stable protein materials [16], that being fully biocompatible can be used to 
favor cell colonization and proliferation when used to decorate flat surfaces [17-20]. In 
addition, as functional biomimetics of hormone secretion granules [21-23], bacterial IBs 
penetrate mammalian cell membranes and release their forming protein for a 
therapeutic effect, when exposed to cultured target cells in form of Nanopills [24-26] 
(top-down) or as Bioscafolds [27] (bottom-up). In the last case, the IB-embedded 
protein results available intracellularly and extracelularly, what expands the diversity of 
situations under which this platform could be applied, The rational for the sustained 
protein release is a sponge-like amyloid organization in which releasable functional 
protein is embedded in non-toxic amyloid fibril networks [22]. In this study, we have 
determined how IBs can be used to functionalize 3D scaffolds formed by several 
promising biomaterials, and at which extent, the functional protein carried by IBs could 
be released and become available to mammalian cells in 3D architectonic settings with 




Materials and methods 
IB production and purification 
Reporter IBs were formed by a variant of EGFP (VP1GFP), that when synthesized in 
bacteria self-organize as mechanically stable and highly fluorescent sub-micron 
particles [20]. These materials were produced in Escherichia coli JGT4 (ClpA-; 
clpA::kan, araD139 (argF-lac) U169 rpsL150 relA1 flbB5301 deoC1 ptsF25 RbsR, SmR) 
[28] in which VP1GFP IBs resulted highly fluorescent [29]. Protein production and IB 
purification were done under standard protocols [24,30]. Briefly E. coli cultures were 
performed in shake flasks in Luria Bertani (LB) medium at 37 °C 250 rpm till reach an 
optical density at 550 nm (OD550) of 0.5. At this point, 1 mM IPTG was added as gene 
expression inducer. Bacterial cultures were further cultured for 3 h at 37 °C and 250 
rpm.  The enzymatic digestion of the bacterial cell wall was carried out by lysozyme at 
1 µg/ml for 2 h at 37C at 250 rpm in the same culture medium. Weakened bacteria 
were disrupted by several freeze/thaw cycles to the samples. IB samples were then 
extensively washed with 0.4 % Triton X-100 (v/v) for 1 h at room temperature and with 
0.025 % NP40 (v/v), for 1 h at 4 °C, and treated with DNAse (at 0.6 µg/ml) for 1h at 37 
°C to remove any potential contaminant DNA.  
IB protein amount was determined through the Quantity One software, on Western 
blots for GFP immunodetection, using a GFP standard curve.  
 
Materials 
Scaffolds fabricated with CHT, PCL and PLA were supplied by Metis Biomaterials SL, 
Valencia (Spain), in form of 1.2 mm thickness and 7.5 mm diameter discs, to be used 
in 48-multiwell plates. PCL (Mw = 48,000) was purchased from Polysciences, PLA (Mw 
= 124,000) was purchased from Cargill-Dow and CHT was purchased from Novamatrix 
(Protasan UP B 80-20). CHT samples (commercial reference: CHT MW48) were 
prepared by freeze-gelation obtaining a global porosity of 90 % and a mean pore size 
of 150 µm. Internal morphology of CHT samples mimic a honeycomb structure. PCL 
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(commercial reference: PCL MW48/12) and PLA (commercial reference: PLA 
MW48/12) scaffolds were prepared by freeze-extraction obtaining a global porosity of 
70 % and a mean pore size of 150 µm. In both cases, pores were interconnected 
(Figure 1). Pore sizes and interconnections were determined by direct measurement 
using SEM micrographs obtained from different samples. For roughness analyises of 
the scaffolds, samples were coated with chromium. Surface studies images were taken 
with a 3D Optical Surface Metrology System Leica DCM 3D microscope (Leica 




Figure 1. Micro-architecture of the 3D biomaterials used in this study.  
 
Scaffold decoration 
3D scaffolds (Metis Biomaterials) were washed three times in PBS for 5 min at room 
temperature and incubated in ethanol 70 % overnight at 4°C to inactivate possible 
contaminants. Then, scaffolds were washed again three times in PBS for 5 min at room 
temperature. Three distinct procedures were implemented to decorate the scaffolds 
with IBs.  
 Injection – IBs resuspended in 0.1 mL PBS (40 µg/ mL final concentration) were 
injected manually in the middle of the scaffold with 1 ml syringe through a 0,8 mm 
diameter needle. Note that IB adsorption to the material necessarily implies the contact 
between the particle and the material surface. In this regard, the flow applied by 
injection seems to hinder this contact in the centre of the scaffold, sweeping along most 
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of the IBs towards more external sections of the scaffolds where the injection flow 
reduces its strength.  
 Dripping – 0.1 mL of the IB suspension (40 µg/ mL final concentration) were 
added drop by drop onto the scaffold surface.  
Dipping – Scaffolds were placed into 5 mL tubes and incubated in 4 mL of IB 
suspension (40 µg/ mL final concentration) overnight at 4°C under gentle rotation to 
favour the contact between IB in suspension and the scaffold. The higher solution 
volume permits to guarantee that the scaffolds are completely submerged, and under 
this IB excess we assume saturating concentrations on the three methods (note that in 
Injection and Dripping all the IB material is in direct contact with the scaffolds). 
 
After IB decoration, scaffolds were washed in PBS for 5 min at room temperature. All 
the procedures were carried out under sterility conditions.  
 
Mammalian cell culture and IB Internalization assay 
HeLa cells (human cervical adenocarcinoma ATCC CCL-2) and 1BR3.G (human skin 
fibroblasts) cells were routinely maintained in α-MEM supplemented with 10 % (v/v) 
fetal bovine serum and 2 mM L-glutamine in a humidified incubator at 37°C and 5% 
CO2. 2·105 HeLa cells suspended in culture medium were seeded by the injection of 
0.1 mL (2·106 cells/ mL), into the middle of the scaffolds. Samples were then 
transferred to 24 well plates and cultured for 24 h in a humidified incubator, at 37°C 
and 5 % CO2. Internalization of IB material was analysed by measuring fluorescence 
linked to HeLa cells after trypsin treatment under two alternative conditions. The “Mild” 
treatment (the regular protocol) used trypsin at 0.5 mg/ mL (final concentration) in 
HBSS for 3 min. The “Harsh” treatment was performed by adding trypsin 1 mg/ mL 
(final concentration), in HBSS for 15 min, and it had been previously designed to 
ensure the complete removal or externally attached protein [31]. The number of 
released cells in both cases was about 100 % of those present in the culture, and no 
significant differences were observed when used IB-decorated or naked PLA scaffolds 
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(65000±10897 for IB-decorated and 57500±17500 for naked respectively in the Mild 
treatment and 65000±23848 for IB-decorated and 65000±23848 for naked respectively 
in the Harsh treatment). Trypsin digestions were done at 37 °C in a humidified 
incubator at 5 % CO2 and under gentle agitation conditions. After protein digestion cells 
were analyzed in a FACSCalibur system (BectonDickinson), using a 15 mW air-cooled 
argon-ion laser at 488 nm. Green fluorescence emission was measured with a 530/30 
nm band pass filter. Data was acquired through CellQuest Pro software and further 
processed using the FlowJo 5.7.2 software. 
 
Gene expression assay, RT-qPCR 
NIH3t3 cells were cultured for 24 h on PLA scaffolds decorated with hFGF-2 IBs, and 
lysed for total RNA extraction with TRIreagent treatment (Sigma- Aldrich, MO, USA) 
according to manufacturer’s instructions. RNA was then quantified in a nanodrop 2000c 
(thermo) and 250 ng of total RNA were reverse-transcribed using  Sperscript III reverse 
transcriptase (Invitrogen S.A, Barcelona, Spain) and oligoDT (promega) as  primer for 
cDNA extension. Real-time qPCR reaction was performed using a 1:5 dilution of the 
the cDNA in a Bio-Rad CFX96 RT-qPCR detection system with SYBR Green PCR 
Supermix (BioRad, Hercules, CA, USA). DNA amplification was detected by 
fluorescence incorporation after each qPCR cycle. The assay was carried out in order 
to determine the expression of the genes Angptl-4 and GAPDH. This last gene, due to 
its constitutive nature, was used to normalize Angptl-4 expression. Gene expression 
was quantified by the comparative analysis of cycle-threshold procedure and it was 
represented as the relative value obtained when comparing cells cultured on IB-
modified PLA scaffolds and on nude scaffolds. Sequences of the primers used in this 
assay were validated by the analysis of the melting curve as well as their efficiency 
curve. All samples were performed in triplicate. RNA controls gave no amplification 
signal. T-test was used to analyze variances between samples. Primer sequences 
were as follow:  Angptl-4 forward: 5’ CAGAGGGACCACTACAGTCCAACTA 3’; Angptl-
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4 reverse: 5’ CACCCTGTCTCCAGTCAGTCAA 3’; GAPDH forward: 
5’ACGGCACAGTCAAGGCCGAG 3’;  GAPDH reverse: 
5’CACCCTTCAAGTGGGCCCCG 3’ 
 
Culture of human mesenchymal stem cells 
Purified human mesenchymal stem cells from bone marrow (hMSC) (CD105+, CD29+, 
CD44+, CD14-, CD34-, CD45-) were purchased from Cambrex Bio Science (Verviers, 
Belgium) and expanded in a defined medium (Cambrex Bio Science). Cells were 
maintained at 37ºC under 5 % CO2 and 95 % air in a humidified incubator. hMSCs were 
seeded on PLA scaffolds in 12-well plates (4×105 cells/well) and cultured for 1 and 4 
days. Cell viability was evaluated using the alamarBlue assay (Biosource, Nivelles, 
Belgium), which incorporates a nonfluorescent redox indicator that turns into a bright 
red fluorescent dye in response to metabolic activity. 
 
Confocal imaging and IB scaffold penetration analysis 
Polymer scaffolds were mounted on Mat-Teck culture dishes (Mat Teck Corp., 
Ashland, Massachusetts, United States) and images were taken with a TCS-SP5 
confocal laser scanning microscope (Leica Microsystems, Heidelberg, Germany) using 
a Plan Apo 10x / 0.4 (dry) objective. GFP-based IBs were excited with an Argon laser 
(488 nm) and the emission was detected in the 500-560 nm range. Polymer matrices 
were collected in reflection mode with a 488 nm Argon laser and detected in the 480-
495 nm range. Hoechst 33342 DNA labels (20 µg/ml, Molecular Probes) was excited 
with a blue diode (405 nm) and detected in the 415-460 nm range. To determine the 
3D polymer microstructure and distribution of IBs, stacks of 40 to 100 sections were 
collected every 4 μm along the material’s thickness. Image processing was performed 
using the Imaris X64 v. 6.2.0 software (Bitplane; Zürich, Switzerland). Quantification of 
integrated fluorescence intensity (IF) of IBs versus scaffold depth was carried out using 
the Metamorph software package v. 5.0r1 (Universal Imaging Corporation Downington, 
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PA, USA). The images were segmented into foreground and background by setting a 
threshold, which was the same for all the samples. Blue self-fluorescence of the 
materials was minimized digitally.  
 
Scanning electron microscopy  
Scaffolds were mounted on copper stubs, and gold sputtered for scanning electron 
microscopy (SEM). The samples were observed with a JEOL JSM5410 scanning 
microscope under an acceleration tension of 10 kV.  
On the other hand, purified IBs were deposited onto Track-Etched polycarbonate 
membranes with 0.2 µm pore size (Whatman, UK) and fixed in 2.5% (v/v) 
glutaraldehyde in 0.1 M PBS. Samples were then dehydrated and the CO2 critical point 
was carried out by conventional procedures [27]. Samples were then mounted on 
adhesive carbon films and gold sputtered for observation in a Hitachi S-570 scanning 
microscope (Hitachi Ltd., Japan) at an accelerating voltage from 15kV to 20kV. 
 
Results and discussion 
VP1GFP IBs produced in a ClpA- background were fully fluorescent inside the 
producing bacteria (Figure 2 A) and once they had been isolated (Figure 2 B). They 
showed a smooth surface and a pseudo-spherical geometry with a diameter ranging 





Figure 2. Geometry and bioactivity of IBs used in this study. A) Fluorescent IBs during 
biofabrication in ClpA- E. coli cells. Intensity of fluorescence ranged from low (dark 
colors) to high (white) (inset). B) Isolated ClpA- IBs upon cell disruption and washing. 
C) SEM images of ClpA- IBs showing spherical geometry and smooth surface. Size of 
the particles ranged between 300 and 400 nm. 
 
The penetrability of these particles into PCL, PLA and CHT 3D scaffolds was tested 
with three different approaches: injection, dipping and dripping. We determined the 
fluorescence versus the distance from the scaffold surfaces upon decoration. In the 
three scaffolds, the highest emission were observed when the scaffolds were exposed 
to IBs through dipping (Figure 3 A), while injection was clearly the least favourable 
protocol under the tested conditions. Using dipping under our condition set, the amount 
of IBs peaked between 200 and 300 µm from the surface in PCL and PLA, while the 
other two methods did not permit the material to accumulate IBs above 100 µm. In 
CHT, the three approaches allowed the IBs to accumulate to similar depths (less than 
100 µm), but again, dipping led to the retention of higher amounts of fluorescent 
material. The maximum depth to which the protein particles penetrated around 300 µm 
in all cases, and no significant levels of fluorescence were detected beyond this 
distance (Figure 3 A). Although the longitudinal penetrability of the protein particles in 
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CHT was clearly limited, the total amount of protein material that was embedded was 
slightly higher in this scaffold than in PCL or PLA (Figure 3 B). This difference is 
probably due to a higher solvent-material surface ratio being in the CHT scaffolds 
where the IBs can get in contact to the material surface more easily. Pore size, being 
the same in the three scaffolds, should not be a differential parameter. However, 
looking at the architecture of the 3 different matrices (Figure 1) a higher degree of 
cavity interconnection is apparent in PLA and PCL scaffolds comparing to CHT, in 
which the inner surfaces show a rather tubular organization. The amount of IBs 











Figure 3. Penetrability of IBs into 3D scaffolds fabricated by alternative materials. A) 
Depth of fluorescence from the scaffolds’ surface, upon decoration with ClpA- IBs. The 
scaffolds were decorated by exposition to IBs through three alternative procedures 
(namely injection, dipping and dripping). B) Integrated fluorescence intensity upon 
dipping is comparatively shown in the three types of scaffolds.  
 
This fact could explain the tendency of CHT scaffolds to accumulate particles near the 
scaffold surface. In addition, fine surface analysis of these scaffolds with DCM revealed 
that CHT owns the highest roughness values Ra, Rq and Rz (Figure 4, Table 1), 
probably due to its tubular organization, which could also contribute that IB particles 
accumulate near the surface. However, Rsk (skewness), which measures the 
symmetry of the deviation from a mean plane, was more negative on PCL and CHT 
than on PLA. This means that, comparatively, PLA has more peaks than valleys. On 
the other hand, PLA had the highest Rku values, a parameter that describes the 




Figure 4. Topography images of the naked scaffolds obtained with the 3D Optical 
Surface Metrology System Leica DCM 3D used for a roughness study. 
 
 





Parameter a PCL PLA CHT 
Ra 36.84±1.46 b 51.34±2.28 69.69±2.10 
Rq 48.29±1.71 70.25±3.35 91.26±2.66 
Rz 230.14±7.1 349.5±16.57 421.79±7.00 
Rsk -0.18±0.04 0.07±0.09 -0.16±0.09 
Rku 4.33±0.09 5.42±0.14 3.63±0.15 
a   Values are given in microns. 




Figure 5 shows 3D image reconstructions of the decorated materials in which both the 
particulate nature of the fluorescent material and the random distribution of the IBs can 
be observed. This indicates that the IBs are both mechanically and functionally stable 
during decoration and also that there are no massive aggregation, although moderate 
clustering was observed in CHT. In addition, the images indicated the absence of hot 
spots in the decoration process, and thus the entire solvent-exposed surface is 





Figure 5. Decoration of 3D scaffolds with GFP IBs (green fluorescence) using different 
methods. Confocal projections of stacks of 70 to 90 sections with a z step of 4 µm. The 
scaffold is detected by reflection (grey). The magnification is equivalent in all panels. 
 
When using IB-decorated 3D scaffolds for cell culture, cell penetrability and adhesion 
occurred correctly, and the cells distributed homogeneously through the inner surfaces 
of the scaffolds (Figure 6). No signs of toxicity promoted by IB decoration were 
observed in cells growing on any of these materials, as revealed by MTT assays 
(Figure 7 A), what prompted us to go further in the analysis of cell behavior in these 
materials. In 2D polystyrene surfaces, when non-treated for cell culture, IBs favored 
cell adhesion and mechanical stimulation of proliferation [17] (what was also observed 
on PLA surfaces (Figure 7 A), and we wondered at which extent this effect could be 
17 
 
also observed in 3D substrates. For that,  3D  PLA scaffolds, that looked specially 
promising in the above experimental were decorated and tested in prolonged culture of 
hMSC, to anticipate a real application in a regenerative medicine context. As observed 
(Figure 7 B), IBs did not result toxic to the cells but in contrast, protein particles clearly 
favored cell proliferation and colonization of the substrate. This indicated that even in 
3D environments, probably offering better conditions for mechanical stimuli than 2D 
surfaces, bacterial IBs are still able to favor colonization through topological 
enhancement of cell division, even of cells such as MSC whose culture require special 




Figure 6. Cell colonization of IB-decorated 3D scaffolds. GFP IBs produce a green 
signal, scaffolds are detected by reflection (grey signal), and cell nuclei are labelled 
with Hoechst 33342 (blue signal). Confocal images are stacks of 70-90 sections. The 






Figure 7. Cell growth of IB-decorated scaffolds. A) Relative number of 1BR3.G cells 48 
hours after culture on flat CHT, PCL and PLA surfaces, naked (-) or decorated with IBs 
(+). B) Proliferation of hMSC cells in 3D PLA scaffolds at different times of culture, in 
absence (-) or in presence of IBs (+), given by units from the alamarBlue assay. 
 
IBs show a natural penetrability into cellular membranes [24,27], offering promise as 
delivery systems of the proteins that form them [21,22,24,26]. In order to explore 
whether functional IB protein could be available to growing cells as presented in 3D 
scaffolds, we determined the percentage of cells incorporating green fluorescence 
upon culture on IB-decorated scaffolds for 24 hours. For that, we removed growing 
cells by a regular trypsin treatment (mild) or by a prolonged (harsh) exposure to the 
protease under conditions in which all the extracellular protein is removed [31]. In 
absence of IBs, no cells were observed to be fluorescent (Figure 8 A). However, an 
important fraction of cells become fluorescent when cultured on IB-decorated scaffolds 
(Figure 8 A). In PLA, that was further explored for IB-protein delivery, the fraction of 
fluorescent cells slightly decreases with time (Figure 8 B), concomitant with the 
increase in the cell number observed when culturing on this material (Figure 7 A). This 
fact strongly suggests that most of the IB material penetrates cultured cells early upon 
seeding, and that the functional protein from IBs remains available intracellularly for 
long time periods, sufficient in the tissue engineering context to provide biological 
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inputs to cultured cells. Internalization of IBs into cell membranes was further visually 
confirmed by 3D reconstructions of stacked confocal images in PLA-decorated cultures 







Figure 8. Penetration of IB material into cultured cells. A) Retention of green 
fluorescence by HeLa cells cultured on IB-decorated scaffolds after removing 
extracellular protein with Mild and Harsh Trypsin treatments. The column on the left 
shows HeLa cells cultured on naked scaffolds and removed by Harsh treatment. Y Axis 
corresponds to red fluorescence, represented to discriminate self-fluorescent cells. B) 
Time-dependence of the relative number of fluorescent cells growing on IB-decorated 
PLA scaffolds, as revealed by Harsh treatment. C ????????? 
 
Upon statistics data analysis, we observed that between 80 and 90 % of cells retained 
fluorescence when detached by a mild trypsin treatment, irrespective of the material 
with which the scaffold is constructed (Figure 9 A). This indicates a homogenous 
dispersion of both IBs and cells on the materials’ inner surfaces and also, an intimate 
contact of the membranes of the majority of cells with IBs, which promotes the 
retention of functional (fluorescent) GFP. In PCL, all the fluorescent cells have 
incorporated the fluorescence intracellular, while in PLA, a minor fraction of fluorescent 
cells retained GFP from IBs only associated to the external side of the cell membrane, 
and this material was removed by a harsh trypsin treatment (Figure 9 A). In CHT, about 
half of IB-exposed HeLa cells retained fluorescence only extracellularly (Figure 9 A), 
indicating that in this scaffold, internalization of IB protein was less efficient than in the 
other tested scaffolds. Its positive charge due to -NH3 groups (while PCL and PLA are 
negatively charged due to their superficial -COOH groups) might contribute to this 
differential protein uptake, as IBs exhibit a negative surface charge [32] and 







Figure 9. Cell penetrability of functional IB protein as released from IB-decorated 3D 
scaffolds. A) The fluorescent cell fraction resulting from subtracting Harsh from Mild 
data represents the efficiency of IB protein internalization. B) Induction of Angptl-4 
gene expression in PLA scaffolds decorated with FGF IBs. In both cases data were 
obtained in triplicate and statistically significant differences (p<0.01) are indicated. 
 
Although these data obtained with a reporter fluorescent protein already indicated that 
protein uptake involved functional protein forms (fluorescent in this case), we wanted to 
confirm the occurrence of appropriate cells responses during the delivery of a 
biologically relevant protein. For that, we decorated 3D PLA scaffolds with IBs formed 
by the fibroblast growth factor 2 (FGF-2), that are fully active [33]. Angptl-4 encoding 
the proangiogenic factor Angiopoietin-like 4 has been previously shown to be up-
regulated in NIH3t3 cells in presence of FGF-2 [34]. As expected, cells cultured on 
scaffolds functionalized with FGF-2 IBs showed a 2-fold increase in the expression of 
Angptl-4 (Figure 9 B), a result that fully confirms the cellular responsiveness of cells to 
protein factors released from IB-based 3D, functional cell culture platforms. 
 
In summary, data presented here present 3D scaffolds formed by polymers as fully 
decoratable with active IBs, representing an interesting approach to the generation of 
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generic platforms for the multifactorial control of 3D cell culture. Among the tested 
materials, PLA was particularly good in allowing the penetration and retention of 
functional IBs up to around 300 µm in depth, being the dipping protocol as developed 
here the most proficient approach for IB decoration. In this material, growing cells 
internalized very efficiently functional protein from reporter IBs, what opens intriguing 
opportunities to design 3D hybrid matrices for the sustained release of functional 
proteins from IBs. Contrarily, CHT was only moderately penetrated by IBs and, in 
addition, only 50 % of the cells in contact with IBs efficiently internalized functional 
protein. Whether limited penetrability and moderate capabilities to allow intracellular 
protein delivery in this material are related events remains unclear, but apparently, both 
parameters are not mechanistically connected. 
 
In the emerging field of tissue engineering, providing appropriate mechanical and 
biological stimuli is a way of mimicking the natural environment for the proliferation and 
eventual differentiation of mammalian cells [1,5,9]. Biodegradable materials, once 
structured in 3D scaffolds, are promising supports for both in vitro and in vivo 
generation of 3D tissue. Among the available functional, non-toxic amyloids [35-37], 
bacterial IBs are very efficient as nano- micro-particulate proteinaceous entities that, as 
they are fully compatible, can be used in biomedical interfaces such as those occurring 
in cell culture [16-18,20,27,38,39]. The sponge-like molecular organization of IBs [40], 
in which fibrils provide mechanical stability for embedding quasi-soluble proteins [22], 
provides a structural basis for the slow release of proteins inside contact cells, that take 
advantage of the natural membrane penetrability shown by IBs [24,27]. Due to the easy 
production, biocompatibility, functionality and tuneability of IBs [41], these particles 
have become a promising biomaterial for protein replacement and cellular therapies, 




Previous research on mammalian cell culture supported by IBs has been performed in 
2D surfaces [20,33,42,43], which show a limited applicability in real tissue engineering 
problems. How IBs would perform in 3D scaffolds was fully unpredictable, and 
specially, the intimate interaction observed between IBs and cell membranes [24] could 
result impaired by the geometry of the scaffolds. Results presented here have shown a 
good penetrability of the protein particles in the tested materials (Figure 3) and an 
excellent performance in promoting cell proliferation, even of sensitive mesenchymal 
cells, in absence of toxicity (Figure 6). This was unexpected as 3D materials offer more 
mechanical stimuli to cell than their 2D counterparts. More importantly, protein drugs 
can be extracellularly and intracellularlly delivered from IB forms (Figure 7, 8), as in 
decorated scaffolds IBs can penetrate the cytosolic membrane and release active 
protein for biological activity. The unexpected ability of bacterial IBs to get embedded 
into or to cross mammalian cell membranes has been reported in detail elsewhere 
[24,27]. This fact is useful in regenerative medicine and could be used to design 
appropriate combinations of growth factors and other protein-based effectors, as 
importantly, essentially any protein of interest can be packaged as functional IBs [21]. 
Also, the principle of protein release from therapeutic IBs has been already proved, 
among others, for Hsp70 [24], keratin 14 (K14) [26], FGF-2 [27], leukemia inhibitory 
factor (LIF) [24], granulocyte-colony stimulating factor (G-CSF) [44] and catalase [24]. 
The potential offered by protein drug delivery from IB-decorated 3D scaffolds offer a 
versatile platform for the controlled release of growth factors and other protein drugs. 
Being not restricted to a specific protein or materials, it offers a plethora of 
opportunities and potential future applications in tissue engineering. 
 
Finally, it can be envisaged that IBs, which are active once adsorbed on biopolymers, 
could be suitable for functionalizing hard materials such as ceramics and metals. 





3D scaffolds formed by PCL, PLA and CHT can be efficiently decorated by dipping 
(and less efficiently by dripping and injection) with bacterial IBs formed by functional 
protein, without loss of protein stability and biological activity. IBs reach deeper than 
300 µm, homogeneously covering the inner surfaces of the materials. Decoration is 
especially competent in PCL. Upon cell culture in these scaffolds, about 80 % of cells 
are in contact with the IB protein, proving the absence of important empty surfaces 
upon decoration. In PCL, essentially all (100 %) these cells internalize functional IB 
protein, and internalization also occurs, at lesser extent, in PLA (around 85 %) and 
CHT (around 50 %). The study presented here support the decoration of polymeric 3D 
scaffolds as a way to generated hybrid scaffold-bioscaffold matrices for the robust 
delivery of biologically active protein drugs with sustained biological effects, formulated 
as bacterial IBs, to mammalian cells. This platform show promise in offering, at the 
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